MICROSATELLITE STABLE COLORECTAL CANCER
Clinical trials for MICROSATELLITE STABLE COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE STABLE COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for MICROSATELLITE STABLE COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug attack tested against Tough-to-Treat cancers
Disease control CompletedThis study tested a new combination of two drugs, NT-I7 and pembrolizumab, for people with advanced solid tumors that had returned or stopped responding to prior therapies. The main goals were to find a safe dose and see if the combination could shrink tumors in several hard-to-t…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: NeoImmuneTech • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Immunotherapy trial shows promise for shrinking advanced colon tumors
Disease control CompletedThis completed Phase 2 trial tested whether the immunotherapy drug nivolumab, either alone or combined with other cancer drugs, could meaningfully shrink tumors in people with advanced colon cancer that had returned or spread. The study enrolled 385 participants whose tumors had …
Matched conditions: MICROSATELLITE STABLE COLORECTAL CANCER
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC